Encompass Health (NYSE:EHC) Q4 2025 Earnings call February 06, 2026 10:00 AM ET Company ParticipantsAndrew Mok - DirectorDoug Coltharp - EVP and CFOJared Haase - Equity Research AssociateMark Miller - Chief Investor Relations OfficerMark Tarr - President and CEOPatrick Tuer - EVP and COOWhit Mayo - Senior Managing DirectorConference Call ParticipantsAnn Hynes - Senior Healthcare Services Equity Analyst and Managing DirectorBrian Tanquilut - Senior Analyst in Healthcare Services, and HCIT/Digital Health Equi ...

Encompass Health (NYSE:EHC) Q4 2025 Earnings call February 06, 2026 10:00 AM ET Company ParticipantsAndrew Mok - DirectorDoug Coltharp - EVP and CFOJared Haase - Equity Research AssociateMark Miller - Chief Investor Relations OfficerMark Tarr - President and CEOPatrick Tuer - EVP and COOWhit Mayo - Senior Managing DirectorConference Call ParticipantsAnn Hynes - Senior Healthcare Services Equity Analyst and Managing DirectorBrian Tanquilut - Senior Analyst in Healthcare Services, and HCIT/Digital Health Equi ...

Encompass Health (NYSE:EHC) Q4 2025 Earnings call February 06, 2026 10:00 AM ET Speaker9Stand by, your meeting is about to begin. Good morning, ladies and gentlemen. Welcome to today's Encompass Health fourth quarter 2025 earnings conference call. At this time, I would like to inform all participants that their lines will be in a listen-only mode. After the speaker's remarks, there will be a question-and-answer period. If you would like to ask a question during this time, please press star one on your telep ...

2025 Fourth Quarter Earnings Call February 6, 2026 Supplemental information Forward-looking statements The information contained in this presentation includes certain estimates, projections and other forward-looking information that reflect Encompass Health's current outlook, views and plans with respect to future events, including the business outlook, guidance and growth targets, future reimbursement rates, labor availability and costs, the effect of tariffs on costs, legislative and regulatory developmen ...

Core Insights - Encompass Health reported revenue of $1.54 billion for the quarter ended December 2025, reflecting a year-over-year increase of 9.9% [1] - The earnings per share (EPS) for the quarter was $1.46, up from $1.17 in the same quarter last year, indicating a significant improvement [1] - The revenue exceeded the Zacks Consensus Estimate by 0.23%, while the EPS surpassed the consensus estimate by 12.95% [1] Financial Performance Metrics - Net patient revenue per discharge was reported at $22,273, which was higher than the estimated $22,062.08 [4] - The total number of discharges was 67,238, slightly below the estimated 67,407 [4] - Net Operating Revenues from inpatient services reached $1.5 billion, exceeding the estimated $1.49 billion, marking a 9.6% increase compared to the previous year [4] Stock Performance - Encompass Health's shares have declined by 10.1% over the past month, contrasting with a 0.5% increase in the Zacks S&P 500 composite [3] - The stock currently holds a Zacks Rank 3 (Hold), suggesting it may perform in line with the broader market in the near term [3]

Encompass Health (EHC) came out with quarterly earnings of $1.46 per share, beating the Zacks Consensus Estimate of $1.29 per share. This compares to earnings of $1.17 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +12.95%. A quarter ago, it was expected that this rehabilitation hospital operator would post earnings of $1.19 per share when it actually produced earnings of $1.23, delivering a surprise of +3.36%.Over the last f ...

Exhibit 99.1 Investor Relations Contact Mark Miller, 205 970-5860 mark.miller@encompasshealth.com Encompass Health reports results for fourth quarter 2025 and issues 2026 guidance BIRMINGHAM, Ala. - Encompass Health Corporation (NYSE: EHC), the largest owner and operator of inpatient rehabilitation hospitals in the United States, today reported its results of operations for the fourth quarter ended December 31, 2025. Summary results | | | | | Growth | | | | | --- | --- | --- | --- | --- | --- | --- | --- | ...

BIRMINGHAM, Ala., Feb. 5, 2026 /PRNewswire/ -- Encompass Health Corporation (NYSE: EHC), the largest owner and operator of inpatient rehabilitation hospitals in the United States, today reported its results of operations for the fourth quarter ended December 31, 2025. Summary results | Growth | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | Q4 2025 | Q4 2024 | | Dollars | | Percent | | | | | (In Millions, Except Per Share Data) | | | | | | | | | | Net operating revenue | $ | 1,544 ...

BIRMINGHAM, Ala., Feb. 2, 2026 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) today announced the appointment of Cain A. Hayes to its board of directors. Continue Reading Cain A. Hayes Hayes joins the Encompass Health board with significant experience in health care, strategic leadership, human capital management, risk management and governmental regulation. He retired as president and chief executive officer of Point32Health, Inc., a top-20 U.S. health plan, in 2024. Prior to joining Point32Health in 2 ...

Core Viewpoint - Encompass Health Corp. will report its fourth quarter results for the period ending December 31, 2025, on February 5, 2026, and will host an investor conference call on February 6, 2026, to discuss these results [1]. Group 1 - The company is the largest owner and operator of inpatient rehabilitation hospitals in the United States, with a total of 173 hospitals across 39 states and Puerto Rico [3]. - Encompass Health provides high-quality rehabilitative care for patients recovering from major injuries or illnesses, utilizing advanced technology and innovative treatments [3]. - The company has received recognition as America's Most Awarded Leader in Inpatient Rehabilitation by Newsweek and Statista, and is ranked among Fortune's World's Most Admired Companies and Forbes' Most Trusted Companies in America [3]. Group 2 - The investor conference call can be accessed by dialing 800-267-6316 for domestic callers and 203-518-9783 for international callers, with a conference ID of EHCQ425 [2]. - A live webcast and an online replay of the conference call will be available on the company's investor website [2].